What is the treatment for acute bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Bronchitis

Do not prescribe antibiotics for acute bronchitis in otherwise healthy adults—this is a viral illness that requires only symptomatic management and patient education. 1, 2, 3

Initial Assessment: Rule Out Pneumonia First

Before diagnosing acute bronchitis, evaluate for pneumonia by checking these specific vital signs and examination findings 1, 2, 4:

  • Heart rate >100 beats/min (tachycardia)
  • Respiratory rate >24 breaths/min (tachypnea)
  • Oral temperature >38°C (fever)
  • Chest examination findings: focal consolidation, egophony, or fremitus

If all four findings are absent, pneumonia is unlikely and chest x-ray is not needed. 1

What NOT to Do (Critical Pitfalls)

Antibiotics provide no meaningful benefit in uncomplicated acute bronchitis—they reduce cough duration by only half a day while causing adverse effects in 20% of patients (nausea, vomiting, diarrhea, allergic reactions, C. difficile infection). 2, 4, 5

Do not be misled by purulent sputum—this occurs in 89-95% of viral bronchitis cases and does NOT indicate bacterial infection. 2, 3, 6

Avoid these medications that lack evidence of benefit 1, 2, 6:

  • Routine antibiotics
  • Expectorants or mucolytics
  • Antihistamines
  • Inhaled corticosteroids
  • Oral corticosteroids
  • NSAIDs at anti-inflammatory doses

Symptomatic Treatment Options

For bothersome cough 1, 2, 3:

  • Codeine or dextromethorphan may provide modest symptom relief
  • These are the only medications with evidence for short-term symptomatic benefit

For patients with wheezing 1, 2, 3:

  • β2-agonist bronchodilators (like albuterol) may be useful in select patients with audible wheezing
  • Do NOT use routinely in patients without wheezing

Low-risk supportive measures 2:

  • Eliminate environmental irritants (smoke, pollutants)
  • Humidified air treatments
  • Adequate hydration

Patient Education (Essential for Satisfaction)

Set realistic expectations about cough duration 2, 3, 4:

  • Cough typically lasts 10-14 days after the office visit
  • Some patients may have cough persisting up to 3 weeks
  • This is normal and does not indicate bacterial infection

Communication strategies to reduce antibiotic expectations 2, 3, 6:

  • Refer to the illness as a "chest cold" rather than "bronchitis"
  • Explain that patient satisfaction depends on communication quality, not antibiotic prescribing
  • Discuss risks of unnecessary antibiotics: side effects, antibiotic resistance, C. difficile infection

The ONE Exception: Pertussis (Whooping Cough)

Suspect pertussis if 4:

  • Cough persisting >2 weeks
  • Paroxysmal cough, whooping cough, or post-tussive vomiting
  • Recent pertussis exposure

Treatment for confirmed/suspected pertussis 1, 2, 7:

  • Macrolide antibiotic (azithromycin or erythromycin)
  • Isolate patient for 5 days from start of treatment
  • Early treatment (within first few weeks) diminishes coughing paroxysms and prevents spread

When to Consider Antibiotics: High-Risk Patients Only

Reserve antibiotics for high-risk patients with specific criteria 2, 3, 6:

High-risk populations include:

  • Age ≥75 years with fever
  • Cardiac failure
  • Insulin-dependent diabetes
  • Immunosuppression
  • Serious neurological disorders

AND patient must have worsening symptoms suggesting bacterial superinfection 1, 2:

  • Fever >38°C persisting beyond 3 days
  • Significantly worsening dyspnea
  • Clinical deterioration despite supportive care

If antibiotics are warranted in high-risk patients 2:

  • Doxycycline 100 mg twice daily for 7-10 days (first-line for moderate severity)
  • High-dose amoxicillin/clavulanate 625 mg three times daily for 14 days (for severe cases)

Reassessment Plan

Advise patients to return if 1, 2:

  • Cough persists or worsens beyond 10-14 days
  • New fever develops after initial improvement
  • Dyspnea worsens significantly
  • Any signs of pneumonia develop

At reassessment, consider targeted investigations 1:

  • Chest x-ray
  • Sputum culture (if bacterial infection suspected)
  • Peak flow measurements
  • Complete blood count and inflammatory markers (CRP)

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Bronchitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Bronchitis.

American family physician, 2016

Research

Diagnosis and management of acute bronchitis.

American family physician, 2002

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.